PETMED EXPRESS INC short interest in 2025
In 2025, PETMED EXPRESS INC's disclosed short interest ran from 7.29% of shares outstanding on 15 Jan 2025 to 12.63% on 15 Dec 2025, a change of +5.34 percentage points. The year's high was 12.63% on 15 Dec 2025 and its low 6.14% on 15 May 2025, averaging 8.07% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.72 days on 29 Aug 2025. Full history: PETMED EXPRESS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 7.29% (15 Jan 2025)
- End of year
- 12.63% (15 Dec 2025)
- Change
- +5.34 pp
- High
- 12.63% (15 Dec 2025)
- Low
- 6.14% (15 May 2025)
- Average
- 8.07%
- Highest days to cover
- 25.72 (29 Aug 2025)
- SEC filings marked
- 7
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 7.29% | 6.34 | |
| 31 Jan 2025 | 6.23% | 6.17 | |
| 14 Feb 2025 | 7.26% | 3.49 | 10-Q filed, results (8-K) |
| 28 Feb 2025 | 8.22% | 6.51 | |
| 14 Mar 2025 | 7.87% | 8.23 | |
| 31 Mar 2025 | 8.62% | 9.19 | |
| 15 Apr 2025 | 8.56% | 7.40 | |
| 30 Apr 2025 | 7.16% | 10.81 | |
| 15 May 2025 | 6.14% | 11.21 | |
| 30 May 2025 | 7.90% | 15.22 | |
| 13 Jun 2025 | 6.76% | 10.18 | |
| 30 Jun 2025 | 6.49% | 11.79 | results (8-K) |
| 15 Jul 2025 | 7.37% | 10.51 | |
| 31 Jul 2025 | 8.85% | 9.18 | |
| 15 Aug 2025 | 9.57% | 11.57 | |
| 29 Aug 2025 | 9.44% | 25.72 | |
| 15 Sep 2025 | 9.34% | 17.55 | |
| 30 Sep 2025 | 8.51% | 14.06 | |
| 15 Oct 2025 | 8.38% | 23.17 | 10-K filed, results (8-K) |
| 31 Oct 2025 | 7.92% | 13.70 | |
| 14 Nov 2025 | 7.48% | 7.31 | results (8-K) |
| 28 Nov 2025 | 7.63% | 7.45 | |
| 15 Dec 2025 | 12.63% | 1.00 |
See also: PETMED EXPRESS INC's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.